Fri, Dec 26, 2014, 4:41 AM EST - U.S. Markets open in 4 hrs 49 mins

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

biogemfinder 47 posts  |  Last Activity: Dec 16, 2014 3:13 PM Member since: Oct 25, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • who is most likely paid by the doctors who perform amniocentesis. Looks like the author is misinformed and does not understand the difference between definitive test/diagnosis and "screening". The point of tests like MaterniT21 is to make sure its negative, which gives you a peace of mind. However, in rare instances where the test comes out positive, it requirs follow up..more ultrasound, and other pre-natal tests, and of course Amnio to make sure the results are valid or not. If the test is negative there is nothing you should do. However, if it is positive you should follow up. Plain and simple.

    This is a hack job...

  • Reply to

    Smoking Cessation

    by sdsi789 Dec 16, 2014 12:58 PM
    biogemfinder biogemfinder Dec 16, 2014 1:20 PM Flag

    you are simply lying. No phase II only phase III to commence by the end of this year!

  • Reply to

    Smoking Cessation

    by sdsi789 Dec 16, 2014 12:58 PM
    biogemfinder biogemfinder Dec 16, 2014 1:19 PM Flag

    There will not be any phase II. They are talking with FDA for properly designed and powered Phae III (or registrational trial). They may include Chantix as comparator, but not sure. That news has to grab some attention even for a short moment. Then we will have to wait for the results which may take upto 6 months although it should enroll within a month or so!

  • especially if you look at for how much verinata was bought by illumina. With patend dispute with ilmn out of the way, getting royalties paid for all kits and tests conducted by ilmn and its other clients, and the fact that insurance reimbursement is improving every q, I will be surprised if sqnm is not trading above $10 a share by the end of 2015

  • Reply to

    I hate

    by benjiro33 Dec 11, 2014 3:40 PM
    biogemfinder biogemfinder Dec 11, 2014 3:47 PM Flag

    only after we announce or better still -preannounce profitability this q4 and for the foreseeable future the traders and MMs will keep playing and pinch pennies every day. But I expect more stability and steady pps increase form the new year's beginning. All the end year tax selling is done and the sellers will reestablish their positions once the 30 day wash sale rule expires

  • biogemfinder biogemfinder Dec 5, 2014 11:08 AM Flag

    have noticed thatas well. Perhpas buying some ESALY is not a bad idea may not be as manipulated as ARNA

  • biogemfinder biogemfinder Dec 4, 2014 8:38 PM Flag

    spammers are back and pps manipulation as well. But clearly with profitability in the horizon and $50M dollars in the coffers dispelling any need for dilution, shorts days are numbered. Of course they are not counting or discounting future potential at all its not reflected in the stock price. However, with profits and growth guidance we don't need stupid upgrades or analysts help the pps will take care of itself and will jump much more rapidly to make up for the suppressed price.

    Sentiment: Strong Buy

  • (which is next quarter or Q1 of 2015) then there is really no reason to expect the pps will remain low! And with all the improvements in cost of goods and improving reimbursement situation as well as increasing revenues due to ww royalties and deals with Quest/Illumina $18 by 2016 is not too far fetched. Look at other biotechs with nothing in market and you see 5B mkt cap. Shorts and MMS manipulating SQNM will come to an end and being profitable is the way to get that rolling.

    Sentiment: Strong Buy

  • Reply to

    $3.65 at the close

    by btsoi7715 Dec 4, 2014 11:38 AM
    biogemfinder biogemfinder Dec 4, 2014 12:20 PM Flag

    Something tells me that you have shorted this stock yesterday?? Good luck with your crystal ball.

  • biogemfinder biogemfinder Dec 3, 2014 1:24 PM Flag

    All the option call writers for Jan 17 2015. That's whom. They wan to make sure they all expire worthless so keep it as low as possible until them. I doubt they will be writing too many beyond that point. As it is very few have been written beyond the Jan 17 strike date. Also, I have noticed that the fools who used to buy weekly options have finally learned the hard lesson that they were only enriching the MMs buy buying those weekly calls. Volume for weekly options is almost non existent so they can no longer make money by selling call options which is a good thing. The only way to honestly mnake money now is to go long and thats what is going to happen soon and certainly after Jan 17, 2015!

    Sentiment: Strong Buy

  • biogemfinder biogemfinder Nov 28, 2014 5:25 PM Flag

    of course they are counting all (even the free sample) to pad up the script numbers. However, when Symphony does that for Belviq thats a big no no and there are professional self appointed writers who would dismiss that number every time. If anyone still believes that IMS numbers are not manipulated you have to be a numb-nut or a moron. They have those outfits to enrich the hedgefund who are still more than 40M short on arena. But 2015 may be a little too hard for even these well oiled manipulation machine to keep the lid on arena. Just way too many catalysts and more than 50% rise in scripts even at this slow script increase per week!

  • I won't be surprised if it end even or negative by the end of today. We are all use to this sort of manipulation with this stock. In the meantime SVP of OREX sells all her shares and no reaction at all!!

  • biogemfinder by biogemfinder Nov 28, 2014 12:27 PM Flag

    The shorts who sold the last few days since the last SI reporting (closing day) are covering on this last closing day as next trading day is Dec 1st. They want to cover before it gets reported and thats all. They have been doing this for many many cycles. You can bet on Dec 1st - barring any other positive development - the pps will go down until the last SI closing day.

    Sentiment: Strong Buy

  • Reply to

    LOW VOLUME. WHO IS SELLING AT THESE LOW PRICES?

    by yhavocm1 Nov 26, 2014 3:23 PM
    biogemfinder biogemfinder Nov 26, 2014 3:37 PM Flag

    the same idiots who bought weekly calls to enrich the MMS and wall street crooks must be now selling at these rock bottom prices. Who else??

  • What is also encouraging is the fact that Short Interest has steadily declined..which menas the shorts dont expect the pps to go down that much. Also, more than 111000 call options with strikes between $3 and $10 are due to expire on Jan 17, 2015. The option writers would want to hold on to those shares but cash the premiums they have already collected. As a result they will do all sorts of things..naked shorting, buying and selling 100 share lots etc etc to keep the pps from srous trending up until Jan 17th. Once those expire, I expect the pps to rise more freely with or without significant news. Thats because last few weeks even with really important and significant news they kept the pps low or even down making sure that this does not get out of hand! LAstly, the weekly options and options in general does not have thje volume it used to once the drug was approved. Which means that the retail suckers who bought calls in the hopes of cashing in big profits with pps rise, have learned the expensive lesson that only the writers of options make money and the buyers almost always lose it! Arena has taught this lesson quite clearly. And I am encouraged by that fact that options games are no longer as effective as it used to be to steal money from unsuspecting retailers.

    I really hope that by the end of this year: ARENA:
    1. announces P2 trial initiation for PAH
    2. announces approval of Belviq from either Canada or Mexico
    3. announces that they are discussing with the FDA regarding use of Belviq in NASH with overweight as one of the morbid conditions
    4. Finalization of P3 design for Belviq in smoking cessation trial after discussions with the FDA

    Sentiment: Strong Buy

  • Reply to

    NEW SHORT INTEREST 39,144,911

    by bruce_waylong Nov 25, 2014 4:08 PM
    biogemfinder biogemfinder Nov 25, 2014 7:23 PM Flag

    It may not be bad strategy to buy a week before SI reporting date (eg Nov 24/25) and then sell right after the reporting cutoff (e.g Dec 1-2). Looks like they have done that repeatedly to screw us longs and keep their short positions

  • biogemfinder biogemfinder Nov 25, 2014 10:43 AM Flag

    Thats great news because I was wondering why the pps was going down! Now I understand..its another piece of good news!! There will be another presentation next week and we can expect a few cents loss on that day as well!

  • biogemfinder biogemfinder Nov 25, 2014 12:45 AM Flag

    111,000 options expire in Jan 17 2015 strike range from $3 to $10. If the pps goes higher the MMs who have written and sold those calls will have to make available 11M shares. They dont want to deliver those shares only get the premiums from the dummest of all retailers who bought those calls. Weekly options and options in general are the games MMs play to make extra bucks from unsuspecting or stupid or very greedy people who buy options which are way higher than the current prices. Since there are not as many calls writen beyond 2015 Jan, I am hoping that pps will finally be allowed to rise, but until then very unlikley....the writers of options have made 110s of millions of dollars by writing an d selling those calls for the lat 2 years.

    Sentiment: Strong Buy

  • biogemfinder biogemfinder Nov 19, 2014 7:56 PM Flag

    One of the things that has not excited the street may have been no approvals from ANY OTHER COUNTRY! That kind limited the potential severely. Once we get a positive nod from Canada OR Mexico, which could happen any day now, that could spark some interest and will definitely help the scripts to grow a little bit more quickly. Then hopefully, they have Phase 3 smoking trials under way and we get the preliminary results by the end of 2015. With more than 4 years worth of data with no safety issues (or tumor issues), EU refiling should happen soon and that may create some buzz as well.

    But I would have liked to see the management also start accumulating some shares themselves which could add confidence for more retail buyers or institutions. That could also be a trigger. But I have no doubt that the management team is not WS savvy at all and don;t know how to manage their PR/ I think the release of BelPhen data and the smoking cessation data was so poorly handled that it made a mockery out of PR. After the data and their PR, we are sitting at 20% lower SP! Compare that to Orexigen's no new PR where they basically said that IMS numbers dont reflect reality and that Eu submission is progressing on schedule (no guarantees of approval), the stock jumps 50% in just 2-days and the WS is jubilent. Although learning from VVUS and ARNA should have told them that it will take a couple of months or quarters before you can judge anything and Eu approval is not certain at all.

    But such is life. We will have to endure this torture for a few more quarters after which hopefully another approval is in the bag, pipeline progresses (new P2/P3 trials) and BelSmoke Phase 3 is underway and is subscribed very quickly, and that Eu filing is announced. I wont be surprised, in the meantime the thieves take it down to $3.25 area.

    But Yeah..I am as frustrated as anyone who has more than 50K shares and many shares accumulated after 2012.

    Sentiment: Strong Buy

  • biogemfinder biogemfinder Nov 14, 2014 7:56 PM Flag

    I wish there was agood way to contact Jack and the BOD. This is a legitimate issue and with all the potential out thee and PPS at historical lows, it only makes sense that they purchase some stocks to install some confidence. Perhaps they will do that once another country approval is announced or that EU refiling is announced, or BelSmoke P3 is planned. But I do think they would be very stupid not to capitalize on the buzz about treating NASH. EISAI should be pounding the table in PFEs corporate HQs to make this point loud and clear as eisai has preexisting partnerships with Pfizer

CLDX
17.08-0.18(-1.04%)Dec 24 1:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.